Periphagen

Biopharmaceutical company developing HSV-1 vectors for gene therapy and neurologic diseases

placePittsburgh, Pennsylvania, United States calendar_todayFounded 2012 groups2 employees language periphagen.com

Registered entities

Innovation

3 patent families (2 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace steady. Cited 215 times.

YearFilings
20172
20192
20202
20222
20232
20241
20252
20261

Investor mix

1 investor on record.

Investor typeCountShare
Other / undisclosed1100%
Coming soon